• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Rifamycin treatment of tuberculosis in a patient receiving atenolol: less interaction with rifabutin than with rifampin.

作者信息

Goldberg Stefan V, Hanson Daniel, Peloquin Charles A

出版信息

Clin Infect Dis. 2003 Aug 15;37(4):607-8. doi: 10.1086/376648.

DOI:10.1086/376648
PMID:12905149
Abstract
摘要

相似文献

1
Rifamycin treatment of tuberculosis in a patient receiving atenolol: less interaction with rifabutin than with rifampin.在接受阿替洛尔治疗的患者中使用利福霉素治疗结核病：与利福布汀的相互作用比利福平少。
Clin Infect Dis. 2003 Aug 15;37(4):607-8. doi: 10.1086/376648.
2
Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.1997年至2000年在纽约市接受基于利福平或利福布汀治疗方案的HIV感染结核病患者的复发及获得性利福平耐药情况。
Clin Infect Dis. 2005 Jul 1;41(1):83-91. doi: 10.1086/430377. Epub 2005 May 26.
3
Acquired rifamycin resistance in persons with advanced HIV disease being treated for active tuberculosis with intermittent rifamycin-based regimens.在接受基于利福霉素的间歇性方案治疗活动性结核病的晚期艾滋病病毒感染者中获得性利福霉素耐药性。
MMWR Morb Mortal Wkly Rep. 2002 Mar 15;51(10):214-5.
4
Drugs for tuberculosis.治疗结核病的药物。
Treat Guidel Med Lett. 2004 Dec;2(28):83-8.
5
Updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors.关于在服用蛋白酶抑制剂或非核苷类逆转录酶抑制剂的HIV感染患者中使用利福布汀或利福平治疗和预防结核病的更新指南。
MMWR Morb Mortal Wkly Rep. 2000 Mar 10;49(9):185-9.
6
A regimen containing rifabutin for the treatment of tuberculosis in patients intolerant to rifampin.一种含利福布汀的治疗方案，用于对利福平不耐受的结核病患者。
Clin Infect Dis. 2003 Jan 1;36(1):127-8. doi: 10.1086/345532.
7
[Therapeutic efficacy of benzoxazinorifamycin KRM-1648 against experimental murine tuberculosis: (1). A study on the efficacy of short course treatment with the intratracheal and intravenous infection model].苯并恶嗪诺利福霉素KRM-1648对实验性小鼠结核病的治疗效果：（1）. 经气管内和静脉内感染模型的短程治疗效果研究
Kekkaku. 1998 Feb;73(2):53-64.
8
Clinical use of rifabutin, a rifamycin-class antibiotic, for the treatment of tuberculosis (A supplement to the 2008 revision of "Standards for tuberculosis care").
Kekkaku. 2011 Jan;86(1):43.
9
In vitro bactericidal and in vivo therapeutic activities of a new rifamycin derivative, KRM-1648, against Mycobacterium tuberculosis.新型利福霉素衍生物KRM-1648对结核分枝杆菌的体外杀菌及体内治疗活性
Antimicrob Agents Chemother. 1996 Feb;40(2):426-8. doi: 10.1128/AAC.40.2.426.
10
Rifamycin-resistant Mycobacterium tuberculosis in the highly active antiretroviral therapy era: a report of 3 relapses with acquired rifampin resistance following alternate-day rifabutin and boosted protease inhibitor therapy.高效抗逆转录病毒治疗时代的耐利福平结核分枝杆菌：3例隔日服用利福布汀和强化蛋白酶抑制剂治疗后出现获得性利福平耐药复发的报告
Clin Infect Dis. 2009 May 15;48(10):1471-4. doi: 10.1086/598336.

引用本文的文献

1
Interactive effect of oral anti-hyperglycaemic or anti-hypertensive drugs on the inhibitory and bactericidal activity of first line anti-TB drugs against M. tuberculosis.口服降糖药或降压药与一线抗结核药物对结核分枝杆菌的抑菌和杀菌活性的相互作用。
PLoS One. 2023 Nov 30;18(11):e0292397. doi: 10.1371/journal.pone.0292397. eCollection 2023.